Bionano Genomics, Inc. — Director's Dealing 2018

Aug 21, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BioNano Genomics, Inc (BNGO)
CIK: 0001411690
Period of Report: 2018-08-21

Reporting Person: Robinson Warren (Chief Commercial Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$64.20	2025-11-08	Common Stock (1168)		Direct
Stock Option (right to buy)	$1.28	2027-02-06	Common Stock (29086)		Direct

Footnotes

F1: 25% of the shares vested on October 12, 2016, and the remaining shares vest in 12 equal quarterly installments thereafter.

F2: 25% of the shares vested on February 7, 2017, and the remaining shares vest in 12 equal quarterly installments thereafter.